App-Quantinova.ai

Risk for Major and Fatal Bleeding After Discontinuing Oral Anticoagulation for Unprovoked Venous Thromboembolism: Systematic Review and Meta‐analysis

F. Khan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

What is the Incidence and Severity of Abnormal Uterine Bleeding Associated with Rivaroxaban in the Treatment of VTE and is there an Impact on Treatment Satisfaction? Early Results from the ‘Follow‐up in Rivaroxaban Patients in Setting of Thromboembolism’ (FIRST) Registry

V. Speed - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

rivaroxaban

Resumption of Anticoagulant Therapy after Anticoagulant‐related Bleeding: A Population‐Based Cohort Study

D. Little - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Prediction of Major Bleeding in Patients Receiving DOACs for Venous Thromboembolism: A Prospective Cohort Study

M.C. Vedovati - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Effect of Polypharmacy on Bleeding of Rivaroxaban Versus Vitamin K Antagonist for Treatment of Venous Thromboembolism

I. Bistervels - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

rivaroxaban

Response to New Oral Anticoagulants in Nigerian Patients with Venous Thromboembolism

W.A. Shokunbi - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Mesoglycan vs Placebo in Secondary Prevention of Superficial Vein Thrombosis. Rationale and Protocol

G. Camporese - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fondaparinux sodium

Clinical Predictors of Pulmonary Embolism for Inpatients: Are Computed Tomography Pulmonary Angiograms Being Requested Appropriately? Retrospective Analysis

L.L.L. Ling - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Thrombosis of the Jugular Veins: What Are the Particularity?

F. Sad - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Methadone hydrochloride

Recurrence Risk According to Anticoagulant Prescribed for the Secondary Prevention of Venous Thrombosis

N. Zakai - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Efficacy and Safety of Apixaban for Treatment of Venous Thromboembolism in a Daily Practice‐based Cohort

S.V. Hendriks - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

apixaban

A Single Centre Retrospective Review of Prophylactic Apixaban Safety and Efficacy in Patients after Venous

A. He - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

apixaban

Venous Thromboembolism in Asia and Worldwide: Emerging Insights from GARFIELD‐VTE

P. Angchaisuksiri - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Outcomes in the Secondary Prevention of Cerebral Venous Thrombosis in Cancer Only Population

N. Abelhad - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Incidence and Characteristics of Venous Thromboembolism in East Asian Primary Central Nervous System Lymphoma

J.M. Byun - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Extended Anticoagulation for Unprovoked Venous Thromboembolism: A Survey on Physicians’ Considerations and Guideline Adherence

M.A. de Winter - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Anticoagulant Treatment Patterns among Venous Thrombosis Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases

A. Keshishian - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

apixaban

Incidence, Risk Factors and Outcomes of Venous Thromboembolism in Haploidentical Versus Matched Related Donor Hematopoietic Stem Cell Transplantation: A 13‐year Retrospective Study of 5471 Recipients

G. Zhang - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Inferior Vena Cava Filters in Venous Thromboembolism: Indications, Complications and Extraction Predictors

F. Chuliber - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Particularities of Upper‐extremity Venous Thrombosis

F. Sad - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Methadone hydrochloride

Filters

7277 Abstracts